15. End-of-Life Patient Population: Pro
Session: Interactive Session: Stewardship: Best Drivers of Change Debate
Wednesday, October 3, 2018: 2:38 PM
Room: N 24
Manisha Juthani-Mehta, MD, FIDSA, FSHEA, Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT

Dr. Manisha Juthani-Mehta is an Associate Professor of Medicine, Infectious Diseases Fellowship Program Director, and Associate Program Director for Career Development for the Internal Medicine Residency Program at Yale School of Medicine. She received a Bachelor of Arts from the University of Pennsylvania and medical degree from Cornell University Medical College. She completed Internal Medicine residency training at New-York Presbyterian Hospital-Weill Cornell and was a Chief Medical Resident at Memorial Sloan-Kettering Cancer Center. Dr. Juthani went to Yale School of Medicine as a post-doctoral fellow in Infectious Diseases in 2002. For the past 15 years, her research has focused on the diagnosis, management, and prevention of infections in older adults, specifically urinary tract infection (UTI) and pneumonia in nursing home residents. She was the first author on an R01 funded clinical trial entitled, “A Randomized Controlled Trial to Reduce Pneumonia in Nursing Home Residents” that was published in Clinical Infectious Diseases. She was also the Principal Investigator of an R01 funded clinical trial entitled, “Cranberry Capsules for Prevention of UTI in Nursing Home Residents” which is submitted for presentation at ID Week 2016. Her new investigative focus relates to the use of antimicrobials at the end of life.


M. Juthani-Mehta, Iterum Therapeutics: Scientific Advisor , Consulting fee .

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.